Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
November 15, 2002

King Pharmaceuticals Has Recalled Liqui-Char

(SafetyAlerts) - The Food and Drug Administration (FDA) released the following information.

PRODUCT
Liqui-Char (activated charcoal, USP), in an Aqueous Base, 15 grams, 2.5 fl. oz. unit dose bottles. Recall # D-037-3;
Liqui-Char (activated charcoal, USP), in an Aqueous Base, 25 grams, 4 fl. oz unit dose tubes and bottles. Recall # D-038-3;
Liqui-Char (activated charcoal, USP), in an Aqueous Base, 30 grams, 4 fl. oz. unit dose bottles. Recall # D-039-3;
Liqui-Char (activated charcoal, USP) in an Aqueous Base, 50 grams, 8 fl. oz. unit dose tubes and bottles. Recall # D-040-3;
Liqui-Char (activated charcoal) in a Sorbitol Base, 25 grams, 4 fl. oz. unit dose tubes and bottles. Recall # D-041-3;
Liqui-Char (activated charcoal, USP) in a Sorbitol Base, 50 grams, 8 fl. oz. unit dose tube. Recall # D-042-3;
Liqui-Char Oral Suspension (activated charcoal) 50 grams, 240 ml unit dose tube. Recall # D-044-3.

CODE
Liqui-Char in an Aqueous Base, 15gm, 2.5 ounce bottles (NDC 52604-8001-05):
J09503 (09/02), K03514 (03/03);
Liqui-Char in an Aqueous Base, 25gm, 4 ounce tubes (NDC 52604-8001-03):
K08506 (08/02), K12501 (12/02), M10501 (10/03), N02505 (02/04);
Liqui-Char in an Aqueous Base, 25gm, 4 ounce bottles (NDC 52604-8001-04):
J11504 (11/02), K01510 (01/03), K01511 (01/03), K03501 (03/03), K03502 (03/03), K03503 (03/03), K5510 (05/03), K05511 (05/03), M01508 (01/04), M06501 (06/04);
Liqui-Char in an Aqueous Base, 30gm, 4 ounce bottles (NDC 52604-8001304):
J08505 (08/02), M01510 (01/04);
Liqui-Char in an Aqueous Base, 50gm, 8 ounce tubes (NDC 52604-8001-06):
K12502 (12/02), M04501 (04/03), M11509 (11/03), M11511 (11/03);
Liqui-Char in an Aqueous Base, 50gm, 8 ounce tubes code:8001E-6:
K09501 (09/02), K09502 (09/02). This product is manufactured for Oxford Pharmaceuticals, Masters House 5 Sandridge Close, Harrow, England, HA11XD;
Liqui-Char in an Aqueous Base, 50gm, 8 ounce bottles (NDC52604-8001-08):
K01506 (01/03), K01509 (01/03), K02513 (02/03), K03519 (03/03), K03520 (03/03), K03521 (03/03), K03522 (03/03), K05512 (05/03), K05515 (05/03), K06501 (06/03), K06503 (06/03);
Liqui-Char in a Sorbitol base, 25gm/27gm (sorbitol), 4 ounce tubes (NDC 52604-8002-03):
K11502 (11/02), K12503 (12/02), M01509 (01/03), M06503 (06/03), M06507 (06/03), M10502 (10/03), M11502 (11/03), N03503 (03/04);
Liqui-Char in a Sorbitol base, 50gm/54gm (sorbitol), 8 ounce bottles (NDC 52604-8002-06):
K08502 (08/02), K09503 (09/02), K09504 (09/02), K09505 (09/02), K10503 (10/02), K11508 (11/02), M02501 (09/03), M04502 (04/03), M07502 (07/03), M11504 (11/03), M12501 (12/03) M12503 (12/03), M12504 (12/03).

RECALLING FIRM/MANUFACTURER
Recalling Firm: King Pharmaceuticals, Inc., Bristol, TN, by letter on August 12, 2002.
Manufacturer: Jones Pharma, Inc., St. Louis, MO.
Firm initiated recall is ongoing.

REASON
Stability; lack of assurance product potency will be maintained through labeled expiration date.

VOLUME OF PRODUCT IN COMMERCE
28,014 units.

DISTRIBUTION
Nationwide, England and Canada.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.